CDK14 and prostate carcinoma: In a study of prostate cancer, miR-1-3p showed downregulation, and its ectopic expression suppressed cell growth and cell cycle progression in vitro and in vivo through targeting of 3′-UTRs of two key cell cycle genes, E2F5 and PFTK1 [42].